Related Experiment Video

Updated: Aug 19, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

CA 125 and survival in ovarian cancer: preliminary communication

D Parker1, K Patel, E J Alred

  • 1Oncology Unit, Bradford Royal Infirmary.

Journal of the Royal Society of Medicine
|January 1, 1988
PubMed

Abstract:

CA 125 is an epithelial membrane marker which can be detected in the serum of patients with ovarian cancer and which may reflect tumour burden. In a group of 42 patients, the level of this marker has also been shown to be significantly related to survival.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Related Experiment Videos

Last Updated: Aug 19, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Articles linked to this work by shared authors, journal, and citation graph.

Out-of-equilibrium quantum magnetism and thermalization in a spin-3 many-body dipolar lattice system.

Nature communications·2019

Bright Soliton to Quantum Droplet Transition in a Mixture of Bose-Einstein Condensates.

Physical review letters·2018

Quantum liquid droplets in a mixture of Bose-Einstein condensates.

Science (New York, N.Y.)·2017

Building confidence in quantitative systems pharmacology models: An engineer's guide to exploring the rationale in model design and development.

CPT: pharmacometrics & systems pharmacology·2016

Competition between Bose-Einstein Condensation and Spin Dynamics.

Physical review letters·2016

Cooling of a Bose-Einstein Condensate by Spin Distillation.

Physical review letters·2015

Seven lessons for financial incentivisation schemes in healthcare: a qualitative study of NHS Resolution's Maternity Incentive Scheme.

Journal of the Royal Society of Medicine·2026

The historical development of sample size estimation: from Huygens and Bernoulli to the present.

Journal of the Royal Society of Medicine·2026

Alfred the Great: a diagnosis.

Journal of the Royal Society of Medicine·2026

Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.

Journal of the Royal Society of Medicine·2026

Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.

Journal of the Royal Society of Medicine·2026

Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.

Journal of the Royal Society of Medicine·2026

Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.

Drug design, development and therapy·2026

Synchronous Low-Grade Appendiceal Mucinous Neoplasm and Neuroendocrine Tumor Presenting as Pseudomyxoma Peritonei: A Case Report.

Cureus·2026

Short communication: Fluorescence preservation of protoporphyrin IX in fresh frozen glioma tissue.

Brain & spine·2026

PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.

Molecular therapy. Nucleic acids·2026

A sequentially activated afterglow probe for AND-gated imaging of alpha-fetoprotein in hepatocellular carcinoma.

Bioactive materials·2026

miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.

Molecular therapy. Nucleic acids·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us